Focus Taiwan App
Download

Adimmune starts COVID-19 vaccine trial

08/27/2020 04:23 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, Aug. 27 (CNA) Taiwanese drug maker Adimmune Corp. on Thursday said it has started the first phase of human trials for its experimental COVID-19 vaccine this week, with Phase 2 likely to follow in November if everything goes well.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.
    172.30.142.52